With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia||St. Jude Children's Research Hospital / Charles Mullighan, MD||Innovation Grants||2019||Tennessee|
|Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma||Children's Hospital of Philadelphia / Michael Chorny, PhD||Innovation Grants||2019||Pennsylvania|
|Therapeutic Targeting of the Disrupted Metabolic State in DIPG||University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD||Innovation Grants||2019||Michigan|
|The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma||Emory University / Anna Kenney, PhD||Innovation Grants||2019||Georgia|
|Developing drugs to treat NT5C2 mediated resistance in pediatric ALL||New York University School of Medicine / William Carroll, MD||Innovation Grants||2019||New York|
|CD36-Sphingosine 1-Phosphate Axis in Osteosarcoma Progression||Medical University of South Carolina / Meenal Mehrotra, MD/PhD||Innovation Grants||2019||South Carolina|
|Identifying targeted treatments for DICER1-associated sarcomas||Research Institute of the McGill University Health Centre / William Foulkes, MD/PhD & Sidong Huang, PhD||Innovation Grants||2019||Quebec|
|Targeting symmetric division in pediatric cancers||Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD||Innovation Grants||2019||Massachusetts|
|Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia||Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD||Innovation Grants||2019||Massachusetts|
|Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy||Dana-Farber Cancer Institute / Jun Qi, PhD||Innovation Grants||2019||Massachusetts|